ANEBULO PHARMACEUTICALS, INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
ANEBULO PHARMACEUTICALS, INC. (ANEB) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $24.50 million as of 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2025-09-29
- 2025-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $24.50M.
- 2024-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $17.80M.
- 2023-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $13.70M.
- 2022-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $8.78M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2025-06-30 | $24.50M 10-K · filed 2025-09-29 |
| 2024-06-30 | $17.80M 10-K · filed 2024-09-25 |
| 2023-06-30 | $13.70M 10-K · filed 2023-09-22 |
| 2022-06-30 | $8.78M 10-K · filed 2022-09-09 |
| 2021-06-30 | $2.37M 10-K · filed 2021-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |